Unicycive Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

(NASDAQ:UNCY), LOS ALTOS, Calif., July 08, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced it has regained compliance with the Nasdaq Stock Market (“Nasdaq”) continued listing standard for minimum share price under Rule 5550(a)(2) of the Nasdaq […]

Glucotrack Announces Repurchase of Series A Warrants

(NASDAQ:GCTK), RUTHERFORD, N.J., July 08, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it has successfully repurchased over 90% of its outstanding Series A Warrants from warrant holders on June 30, 2025. The repurchase

Limitless X Holdings Secures $100,000 Strategic Funding From Chairman to Strengthen Balance Sheet and Demonstrate Leadership Commitment

(Other OTC:LIMX),(OTC US:LIMX), Los Angeles, CA, July 08, 2025 (GLOBE NEWSWIRE) — Limitless X Holdings, Inc. (OTC: LIMX), a multidimensional public company operating at the intersection of health, wellness, entertainment, and complementary high-growth sectors, has completed a $100,000 related-party bridge loan from EM1 Capital, LLC, an entity wholly owned and controlled by Jas Mathur, Chairman

QHS Healthcare, Powered by QHSLab, Inc. (OTCQB: USAQ), Opens Doors in Miami to Expand Access to Mental Health Services

(Other OTC:USAQ),(OTC US:USAQ), Innovative initiative combines QHSLab's digital platform with on-site behavioral health services to advance timely, effective care. MIAMI, FL, July 08, 2025 (GLOBE NEWSWIRE) — QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health company advancing personalized medicine through innovative population health screening and point of care diagnostic tools in primary care, announced

net2phone’s AI Agent Named a 2025 AI Agent Product of the Year Award Winner

(NYSE:IDT), TMCnet award honors net2phone for its innovative solution leveraging artificial intelligence to automate tasks and elevate performance across business functions Newark, NJ, July 08, 2025 (GLOBE NEWSWIRE) — net2phone, a solutions provider of AI-powered communications-as-a-service, today announced that net2phone's AI Agent has been named a 2025 AI Agent Product of the Year Award winner

Thrive Acquires GRC-Focused Abacode

BOSTON, July 08, 2025 (GLOBE NEWSWIRE) — Thrive, a global technology outsourcing provider for cybersecurity, Cloud, and IT managed services, today announced the acquisition of Abacode, a leading Managed Cybersecurity & Compliance Provider (MCCP) based in Tampa, Florida. Abacode specializes in holistic, outcome-driven cybersecurity solutions and governance programs that help businesses transform their cyber risk

Cellebrite Names David Barter Chief Financial Officer

(NASDAQ:CLBT),(NASDAQ:CLBTW), TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 08, 2025 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that David Barter, a proven finance executive with extensive public company CFO experience in technology and software, has been appointed CFO, effective

Hanmi Financial Corporation Announces Second Quarter 2025 Earnings and Conference Call Date

(NASDAQ:HAFC), LOS ANGELES, July 08, 2025 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that it will report second quarter 2025 financial results after the market close on Tuesday, July 22, 2025. Management will host a conference call that same day, at 2:00 p.m. Pacific Time

Patria Announces Second Quarter 2025 Investor Call

(NASDAQ:PAX), GRAND CAYMAN, Cayman Islands, July 08, 2025 (GLOBE NEWSWIRE) — Patria (Nasdaq:PAX) announced today that it will release financial results for the second quarter 2025 on Friday, August 1, 2025, and host a conference call via public webcast at 9:00 a.m. ET. To register, please use the following link: https://edge.media-server.com/mmc/p/rpv5tvp5. For those unable to

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

(NYSE:CLDI), NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) — via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and

Scroll to Top